Order Article Reprints

Krishnan A, Callanan DG, Sendra VG, Lad A, Christian S, Earla R, Khanehzar A, Tolentino AJ, Vailoces VAS, Greene MK, et al. Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials. Pharmaceuticals. 2024; 17(4):481. https://doi.org/10.3390/ph17040481

Krishnan, Anitha, David G. Callanan, Victor G. Sendra, Amit Lad, Sunny Christian, Ravinder Earla, Ali Khanehzar, Andrew J. Tolentino, Valory Anne Sarmiento Vailoces, Michelle K. Greene, and et al. 2024. "Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials" Pharmaceuticals 17, no. 4: 481. https://doi.org/10.3390/ph17040481

Krishnan, A., Callanan, D. G., Sendra, V. G., Lad, A., Christian, S., Earla, R., Khanehzar, A., Tolentino, A. J., Vailoces, V. A. S., Greene, M. K., Scott, C. J., Kunimoto, D. Y., Hassan, T. S., Genead, M. A., & Tolentino, M. J. (2024). Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials. Pharmaceuticals, 17(4), 481. https://doi.org/10.3390/ph17040481